Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin

Diabetologia

Volumn 42, Issue 1, 1999, Pages 60-67

  Neilsen, S ^a   Schmitz, A ^a   Bacher, T ^a   Rehling, M ^a   Ingerslev, J ^b   Mogensen, C E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University Hospital   (Denmark)

Author keywords

Albuminuria; Heparin; Low molecular weight heparin; Microalbuminuria; Transcapillary escape rate of albumin

Indexed keywords

ALBUMIN; TINZAPARIN;

ADULT; AGED; ARTICLE; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCOSAMINOGLYCAN METABOLISM; HEMOSTASIS; HUMAN; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CAPILLARIES; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FIBRINOLYTIC AGENTS; HEMOGLOBIN A, GLYCOSYLATED; HEMOSTASIS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIPIDS; MIDDLE AGED; PLACEBOS; PLASMA VOLUME; SERUM ALBUMIN;

EID: 0032913333     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051114     Document Type: Article

References (48)

1. 1. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J (1993) A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16: 996-1003
2. 2. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5: 126-134
3. 3. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736-741
4. 4. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1: 17-19
5. 5. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360
6. 6. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226
7. 7. Parving HH, Nielsen FS, Bang LE et al. (1996) Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 39: 1590-1597
8. 8. Nielsen FS, Rossing P, Gall MA et al. (1997) Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest 57: 427-434
9. 9. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R (1995) Increased transcapillary escape rate of albumin in Type II diabetic patients. Diabetes Care 18: 1-9
10. 10. Gambaro G, Baggio B (1996) Glycosaminoglycans: a new paradigm in prevention of proteinuria and progression of glomerular disease. Nephrol Dial Transplant 11: 762-764
11. 11. Groggel GC, Hughes ML (1995) Heparan sulfate stimulates extracellular matrix protein synthesis by mesangial cells in culture. Nephron 71: 197-202
12. 12. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L (1997) Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 99: 2062-2070
13. 13. Myrup B, Hansen PM, Jensen T et al. (1995) Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421-422
14. 14. van der Pijl JW, van der Woude FJ, Geelhoed-Duijvenstijn PHLM et al. (1997) Danaparoid sodium lowers proteinuria in diabetic nephropathy. J Am Soc Nephrol 8: 456-462
15. 15. Solini A, Vergnani L, Ricci F, Crepaldi G (1997) Glycosaminoglycans delay the progression of nephropathy in NIDDM. Diabetes Care 20: 819-823
16. 16. Christensen CK, Ørskov C (1984) Rapid screening PEG immunoassay for quantification of pathological microalbuminuria. Diabetic Nephrol 3: 92-94
17. 17. Parving HH, Gyntelberg F (1973) Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 32: 643-651
18. 18. DeFronzo RA (1992) Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 20 [Suppl 11]:S1-S16
19. 19. Ingerslev J (1987) A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 47: 143-149
20. 20. Ingerslev J, Stenbjerg S (1986) Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies. Br J Haemat 62: 325-332
21. 21. Choi SC (1977) Tests of equality of dependent correlation coefficients. Biometrika 64: 645-647
22. 22. O'Hare JA, Ferriss JB, Twomey B, O'Sullivan DJO (1983) Poor metabolic control, hypertension and microangiopathy independently increase the transcapillary escape rate of albumin in diabetes. Diabetologia 25: 260-263
23. 23. Parving HH (1976) Increased microvascular permeability to plasma proteins in short-and long-term juvenile diabetics. Diabetes 25: 884-889
24. 24. Parving HH, Noer I, Deckert T et al. (1976) The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12: 161-166
25. 25. Schmitz A, Hansen HH, Christensen T (1989) Kidney function in newly diagnosed Type II (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 32: 434-439
26. 26. Vora JP, Dolben J, Williams JD, Peters JR, Owens DR (1993) Impact of initial treatment on renal function in newly-diagnosed Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 734-740
27. 27. Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE (1995) Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients - A longitudinal study. Diabetes Care 18: 1434-1441
28. 28. Parving HH, Mogensen CE, Jensen HA, Evrin PE (1974) Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1: 1190-1192
29. 29. Parving HH, Kastrup J, Smidt UM (1985) Reduced transcapillary escape rate of albumin during acute blood pressure-lowering in Type I (insulin-dependent)diabetic patients with nephropathy. Diabetologia 28: 797-801
30. 30. Nørgaard K, Jensen T, Feldt-Rasmussen B (1993) Transcapillary escape rate of albumin in hypertensive patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 57-61
31. 31. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B (1995) Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 88: 629-633
32. 32. Feldt-Rasmussen B (1986) Increased transcapillary escape rate of albumin in Type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282-286
33. 33. Parving HH, Gall M-A, Skott P et al. (1992) Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41: 758-762
34. 34. Fioretto P, Mauer M, Brocco E et al. (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39: 1569-1576
35. 35. Olsen S, Mogensen CE (1996) How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 39: 1638-1645
36. 36. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF (1993) Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118: 129-138
37. 37. Ozata M, Kurt I, Azal O et al. (1995) Can we use plasma fibronectin levels as a marker for early diabetic nephropathy. Endocr J 42: 301-305
38. 38. Stehouwer CD (1996) von Willebrand factor, dysfunction of the vascular endothelium, and the development of renal and vascular complications in diabetes. In: Mogensen CE (ed) The kidney and hypertension in diabetes mellitus. Kluwer Academic Publishers, Boston, Dordrecht, London, pp 155-163
39. 39. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340: 319-323
40. 40. Bruno G, Cavallo Perin P, Bargero G, Borra M, D'Errico N, Pagano G (1996) Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 125: 653-657
41. 41. Brownlee M (1976) alpha1-Macroglobulin and reduced basement-membrane degradation in diabetes. Lancet 1: 779-780
42. 42. Christe M, Gattlen P, Fritschi J et al. (1984) The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy. Thrombosis Haemostasis 52: 221-223
43. 43. Schmitz A, Ingerslev J (1990) Haemostatic measures in Type II diabetic patients with microalbuminuria. Diabet Med 7: 521-525
44. 44. Dvorak HN, Senger DR, Dvorak AM, Harvey VS, McDonagh J (1985) Regulation of extravascular coagulation by microvascular permeability. Science 227: 1059-1061
45. 45. Gambaro G, Cavazzana AO, Luzi P et al. (1992) Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42: 285-291
46. 46. Gambaro G, Venturini AP, Noonan DM et al. (1994) Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46: 797-806
47. 47. Marshall SM, Hansen KW, Østerby R, Frystyk J, Ørskov H, Flyvbjerg A (1996) Effects of heparin on renal morphology and albuminuria in experimental diabetes. Am J Physiol 271:E326-E332
48. 48. Mandal AK, Lyden TW, Saklayen MG (1995) Heparin lowers blood pressure: Biological and clinical perspectives. Kidney Int 47: 1017-1022